This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 14 - 17, 2025
Marriott Marquis San DiegoLive In-Person Event: December 14 - 17, 2025

Frank Beurskens, PhD
Director and Antibody Format Translation Lead at Genmab
Speaker

Profile

Frank Beurskens is Director and Antibody Format Translation Lead at Genmab, where he advances antibody engineering and therapeutic innovation. Since 2002, he has contributed to key research on complement system modulation, antibody structure-function, bacterial and tumor targeting. He holds multiple patents, including innovations in Fc-Fc interactions and hexameric antibody formats enhancing complement activation and immune efficacy.

Agenda Sessions

  • Complement Activation by IgG Subclasses is Governed By Their Ability to Oligomerize Upon Antigen Binding

    3:00pm